
· Executive Brief
World Diabetes Day 2026
An executive-guidance framework for coordinated messaging, visible ownership, and a measured improvement cycle.

Leadership signal
World Diabetes Day can serve as an executive operating checkpoint.
Coordination matters when multiple teams participate. An executive review can prevent conflicting instructions, unowned inquiries, duplicated outreach, and disconnected follow-up by establishing a shared brief, named owners, and a visible exception process.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Diabetes detection is a route problem before it is a campaign
World Diabetes Day arrives each November, but the operating problem it points to runs all year. Many people with diabetes or prediabetes are not yet known to the health system that serves them. A detection study using national examination data noted that about 23% of people with diabetes were unaware of their condition.[12] For executives, that is a detection and follow-through gap, not only a clinical one. It also means that the health system’s own records undercount the people it is responsible for.
Finding a case does not close the gap. In an emergency department screening program across four sites of one health system, 615 of 9,897 screened patients (6.2%) had diabetes.[1] Among surveyed patients who were newly diagnosed, 79% reported obtaining outpatient care, yet only 46% recalled being diagnosed in the emergency department.[1] A result that is not remembered is a handoff that did not fully land.
Prevention depends on the same kind of route. Real-world enrollment in the National Diabetes Prevention Program had an 88% probability of saving money over two years in a large employer-insured population.[14] Yet access to virtual prevention is uneven, because about 30% of potentially eligible Medicare beneficiaries lacked full digital access.[15] Together, these findings frame the opportunity: the prevention service can pay off, but only if people can reach it.
The sections below add peer-reviewed evidence on burden, screening yield, prevention enrollment, food insecurity, regional and rural patterns, technology access, workforce and communication. They sit beside the executive guidance already on this page. Each finding is reported with its own setting and limits, because most of the studies are observational. The aim is a shared factual base for deciding which detection and prevention route to strengthen first, and how to know whether it worked.
Current evidence
What the research says about hidden burden and screening yield
Undiagnosed diabetes is not confined to people who look at risk by conventional markers. In a national U.S. analysis of normal-weight adults, undiagnosed diabetes prevalence was 4.84% among those with clustered metabolic risk factors and 1.28% among metabolically healthy peers.[9] Asian adults had higher odds of undiagnosed diabetes than White adults (odds ratio 6.10), independent of metabolic phenotype.[9] Screening rules that lean on body mass index alone may miss people the system already sees. The study population represented about 60 million U.S. adults, so even small percentages describe a large number of people.[9]
Some clinical populations carry an especially high hidden burden. Among U.S. adults with coronary heart disease and no known diabetes, the weighted prevalence of newly diagnosed diabetes was 22.1%, compared with 6.5% among controls.[5] Initial fasting glucose and HbA1c screening missed 32 of 64 diabetes cases (50.0%), which were detectable only by oral glucose tolerance testing.[5] The authors proposed a triage model to target that added test toward people at highest risk.[5]
Food insecurity sits alongside this burden. In a national sample of 13,937 U.S. adults, 28.4% experienced marginal, low or very low food security.[8] Lower food security was associated with higher odds of obesity, diabetes, weak or failing kidneys and cardiovascular disease, with clear dose-response patterns.[8] Very low food security carried an adjusted odds ratio of 3.69 for congestive heart failure.[8] These are cross-sectional associations, but they place food access inside the diabetes conversation.
Place matters as well. Across 418 Deep South counties, average county-level diagnosed diabetes was 15.6%, with strong correlations with physical inactivity (r = 0.82), poverty (r = 0.74) and food insecurity (r = 0.59).[11] Broadband access was inversely correlated with diabetes burden (r = -0.69), and hotspots clustered in the Mississippi Delta and parts of Alabama and Louisiana.[11] Ecological data cannot describe individual risk, but they show where weak infrastructure and high burden overlap.
Rural detection gaps appear internationally too. In community screening conducted by community health workers in three rural Ugandan districts, overall diabetes prevalence was 11.3%, and 36.4% of diabetes cases were undiagnosed.[13] The pattern across these settings is consistent. A meaningful share of disease stays unseen until someone deliberately looks.[5][13]
Figure 1
Where diabetes detection and follow-through leak
Percent of the stated group, as reported in each study. Values are copied from the cited studies [1], [4], [5], [13], [15]; none is estimated.
Data note. These values come from different studies, populations, countries, years and denominators, so this is an indirect comparison; the bars show where detection routes leak, not how one step compares with another.
Limitation. Each value reflects its own setting; the Ugandan figure is a non-U.S. community sample, and the hand clinic and emergency department figures come from single organizations.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Diabetes cases undiagnosed in community screening | 36.4% | Adults in three rural districts of Uganda, community health worker screening data, 2,587 records | [13] |
| Diabetes cases missed by initial fasting glucose and HbA1c screening | 50% | 32 of 64 cases among U.S. adults, detectable only by oral glucose tolerance testing; national survey cycles 2007 to 2016 | [5] |
| Prediabetes or type 2 diabetes patients without a primary care provider | 43.4% | Patients screened with point-of-care HbA1c in one U.S. orthopedic hand clinic; 84 patients tested | [4] |
| Newly diagnosed patients who recalled their emergency department diagnosis | 46% | Survey of patients diagnosed through screening at four emergency department sites of one U.S. health system | [1] |
| Potentially eligible Medicare beneficiaries with no computer and no internet use | 14.9% | Beneficiaries aged 65 and older with a body mass index of 25 or more and no diabetes history, 2020 national survey | [15] |

Continuum of care
Where detection breaks between a positive screen and an accepted owner
The continuum for diabetes detection begins wherever a person is tested and ends only when a confirmed result reaches an accepted owner. The emergency department study shows how wide that span can be. Investigators surveyed 307 patients diagnosed through screening, a 50% response rate.[1] Among newly diagnosed respondents, 52% reported starting diabetes medication, 65% reported improving their diet and 35% reported increasing exercise.[1]
Those who did not establish care described concrete barriers. They cited not being aware of the screening result, time and scheduling problems, and financial considerations.[1] Each barrier maps to an operational step that someone can own. Result notification, appointment access and cost conversations are system functions, not patient failings. The authors concluded that stronger connections between screening programs and subsequent care are needed.[1]
Opportunistic screening outside primary care creates the same handoff challenge. In an orthopedic hand clinic, point-of-care HbA1c fingerstick testing found 58.3% of 84 patients in the prediabetes range and 4.8% in the type 2 diabetes range.[4] Among patients with prediabetes or type 2 diabetes, 43.4% did not have a primary care provider.[4] A positive result in a specialty office has nowhere to go unless the organization defines a receiving route.
Confirmatory testing is another fragile step. Among adults with coronary heart disease, a two-tier approach that added oral glucose tolerance testing found cases that first-line tests missed.[5] For people with known cardiovascular risk, the design question for leaders is who orders the second test, who reviews it and who accepts the referral that follows.[5] The study’s own model was designed to narrow that added testing to the people at highest risk, enhancing screening efficiency.[5] Without a named owner, a second test becomes an optional step that busy teams skip.
Screening creates value only when it connects to something that happens next. In an Indonesian economic model, pairing screening with effective interventions for prediabetes yielded the lowest cost-effectiveness ratio of the scenarios tested.[7] The same model found that screening every three or five years produced lower ratios than the base case.[7] Cadence and linkage, not test volume, carry the value of a detection program. The Michigan grocery program offers a domestic example of linkage, since its participants were drawn from primary care practices that could track results after enrollment.[6]
Figure 3
Why the pathway breaks
People
- No navigator or named owner for positive screening results
- Community health workers not integrated into routine screening
- Specialty clinicians unsure where to send elevated results
Process
- Positive results not communicated in a way patients remember
- No confirmatory testing step for high-risk groups
- No referral route for patients without a primary care provider
Technology
- Prevention offered only virtually to people without digital access
- Unequal offer and support for glucose monitoring technology
- Risk models deployed without review of whom they miss
Environment
- Food insecurity in the communities served
- Low broadband access in high-burden counties
- Rural distance from clinics and testing
Policy
- Cost and scheduling barriers to follow-up care
- Screening rules that rely on body mass index alone
- Prevention programs not linked to screening programs
Measurement
- Screening counted without tracking connection to care
- Results not stratified by race, ethnicity, language and place
- Campaign reach not measured by community
Unranked qualitative cause-and-effect diagram for the outcome in the box: People with undiagnosed diabetes or prediabetes are not detected, or are detected but never reach an accepted owner for follow-up and prevention Causes are assembled from the cited literature [1], [3], [4], [5], [8], [9], [11], [12], [13], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | No navigator or named owner for positive screening results; Community health workers not integrated into routine screening; Specialty clinicians unsure where to send elevated results |
| Process | Positive results not communicated in a way patients remember; No confirmatory testing step for high-risk groups; No referral route for patients without a primary care provider |
| Technology | Prevention offered only virtually to people without digital access; Unequal offer and support for glucose monitoring technology; Risk models deployed without review of whom they miss |
| Environment | Food insecurity in the communities served; Low broadband access in high-burden counties; Rural distance from clinics and testing |
| Policy | Cost and scheduling barriers to follow-up care; Screening rules that rely on body mass index alone; Prevention programs not linked to screening programs |
| Measurement | Screening counted without tracking connection to care; Results not stratified by race, ethnicity, language and place; Campaign reach not measured by community |
Access
Making prevention, testing and healthy food reachable
Access to prevention increasingly runs through digital channels. Among Medicare beneficiaries aged 65 and older with a body mass index of 25 or more and no diabetes history, 70.8% had a computer and used the internet.[15] Another 14.3% had one or the other, and 14.9% had neither.[15] Hispanic and non-Hispanic Black beneficiaries were less likely than non-Hispanic White beneficiaries to have both (odds ratio 0.28).[15] The authors estimated that about 6 million potentially eligible beneficiaries lacked full digital access.[15]
That gap matters because the prevention program appears worth reaching. In a real-world study of 5,948 adults with prediabetes in a large employer-insured workforce, each enrollee had an average reduction of $4,552 in two-year direct medical costs compared with nonenrollees.[14] The confidence interval for that estimate crossed zero, and quality-adjusted life-years did not differ.[14] Even so, enrollment had an 84% probability of being cost-effective at $100,000 per quality-adjusted life-year.[14]
Food access can be addressed through logistics rather than advice alone. A Michigan quality improvement program enrolled 83 adults with type 2 diabetes and low income or food insecurity from 21 primary care practices.[6] Participants received $80 each month for eligible healthy groceries delivered to them, plus low-carbohydrate education, for three months.[6] HbA1c fell by an average of 0.4% overall and 0.7% among those with uncontrolled baseline values.[6]
That program had no control group, so it cannot show what would have happened without it.[6] Its lesson for executives lies in the design: a low-burden, practice-based route that removed a logistical barrier instead of asking patients to overcome it. The authors described it as a feasible approach for people with type 2 diabetes and food insecurity or low income.[6] Overall weight fell by 1.7% from baseline, a smaller change than the HbA1c result, and the weight change was not significant among people not using GLP-1 receptor agonist medicines.[6]
Testing access follows the same logic. The hand clinic team described point-of-care HbA1c testing as a low-cost and rapid option that could be incorporated into routine specialty visits.[4] When testing happens where people already are, and the result has a defined next owner, access improves without asking patients to make an extra trip.[4] Rural communities need the same principle at greater distance. In the Ugandan program, screening was brought to adults in their own districts by community health workers rather than waiting for clinic visits.[13] Access, in this sense, is a decision about where the first test happens.
Executive guidance · System route
Build one visible operating route for World Diabetes Day.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Define the purpose
- Align the entry point
- Support longitudinal navigation
- Manage response
- Review the campaign
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Define the purpose
Name the audience, intended action, approved message, and limits of what the campaign can responsibly promise.
Align the entry point
Connect every communication channel to current information and a clearly identified receiving role or team.
Support longitudinal navigation
Make entry points, education, service ownership, transitions, and follow-through visible across the locally defined route without prescribing care.
Manage response
Keep questions, referrals, exceptions, and unresolved work visible until an accountable receiver accepts them.
Review the campaign
Compare intended action with local process signals and partner feedback, then document the improvement to carry forward.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Define the purpose | Name the audience, intended action, approved message, and limits of what the campaign can responsibly promise. |
| Align the entry point | Connect every communication channel to current information and a clearly identified receiving role or team. |
| Support longitudinal navigation | Make entry points, education, service ownership, transitions, and follow-through visible across the locally defined route without prescribing care. |
| Manage response | Keep questions, referrals, exceptions, and unresolved work visible until an accountable receiver accepts them. |
| Review the campaign | Compare intended action with local process signals and partner feedback, then document the improvement to carry forward. |
Equity and trust
Equity gaps run from detection into technology and prevention
Equity gaps extend from detection into the technologies that support diabetes care. A meta-analysis pooled 18 U.S. studies with 955,556 individuals.[3] Black or African American individuals (odds ratio 0.47) and Hispanic individuals (odds ratio 0.59) were less likely than non-Hispanic White individuals to use continuous glucose monitoring.[3] Gaps were wider for insulin pumps, with odds ratios of 0.31 and 0.48 respectively.[3]
The authors noted moderate to substantial heterogeneity and reliance on electronic medical record data.[3] Those limits do not erase the direction of the finding. They point leaders toward stratified review of who is offered, prescribed and supported in using technology, alongside who is screened.[3] Asian individuals were equally likely to use continuous glucose monitoring, which shows that gaps are not uniform across groups.[3] Technology access belongs in the same equity review as detection, because people found through screening will later depend on these tools.
Undiagnosed disease is also unevenly distributed. Asian adults of normal weight had higher odds of undiagnosed diabetes than White adults, which suggests that rules built on weight thresholds may not serve every community equally.[9] In the Deep South analysis, diabetes hotspots co-occurred with higher poverty and higher proportions of non-Hispanic Black residents.[11] Primary care physician availability was inversely correlated with county burden (r = -0.28).[11]
Digital equity and prevention are closely linked. The Medicare analysis found lower full digital access among Hispanic and non-Hispanic Black beneficiaries, so a virtual-only prevention offer may widen gaps rather than narrow them.[15] The inverse county-level correlation between broadband access and diabetes burden points the same way.[11] Equitable access means offering more than one route into the same program. Food insecurity adds another layer, since lower food security was associated with higher odds of diabetes in a dose-response pattern.[8] A prevention offer that ignores food access asks the most burdened households to do the most work.
Trust grows when programs are shaped with and for the people they serve. Hawai’i’s statewide campaign focused on Native Hawaiian, Other Pacific Islander and Filipino communities, who experience high rates of prediabetes and diabetes but low prevention program enrollment.[2] Campaign exposure did not differ significantly across ethnicities, and the target groups were deliberately oversampled in the evaluation.[2] Measuring reach by community is itself an equity practice.

Human infrastructure
The people who find cases and keep prevention going
Detection and prevention depend on people whose roles are often informal or thinly funded. In rural Uganda, screening data from 2,587 records collected by community health workers identified a high proportion of undiagnosed diabetes.[13] The authors concluded that engaging community health workers in routine screening and awareness programs can reduce the undiagnosed burden.[13] Their work extends the reach of a health system into places where clinics are few.
Clinicians outside primary care can also widen detection. The hand clinic study concluded that hand surgeons can successfully identify patients with elevated HbA1c, particularly in the prediabetes range, where the condition is more reversible.[4] That only becomes a workforce asset if someone accepts the referral, which matters when 43.4% of those identified lacked a primary care provider.[4]
Prevention delivery is itself a workforce question. Lifestyle coaches and program staff deliver the sessions that make enrollment worthwhile. A 16-session, four-month program for Black breast cancer survivors, built on the Diabetes Prevention Program core curriculum with added stress management content, enrolled 90.9% of eligible women.[10] Ninety-five percent of participants attended at least 70% of sessions.[10] Tailored delivery requires staff time and design skill that budgets should recognize. Retention was complete, with every participant finishing both the baseline and four-month assessments.[10] That kind of engagement reflects coaching capacity as much as curriculum.
Practice teams carry much of the operational load. The Michigan grocery program drew participants from 21 primary care practices and used medical record data to track HbA1c, weight and medication changes for 12 months after enrollment.[6] Programs like this rely on clinic staff to identify eligible patients and keep records current, which is work that rarely appears in staffing models. Medication review was part of that work: most medications had no change in dosing, while slightly more were increased or added than decreased or stopped.[6]
Navigation is the missing role in several of these studies. Emergency department patients who did not follow up cited unawareness of results and scheduling problems, both of which a navigator or result-communication role could address.[1] Executives can ask a simple question of every screening program: who owns the call after a positive result, and how many results can that person carry?[1]
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Message alignment
Do channels and partners communicate one current and appropriately bounded route?
- Candidate local measure
- Content review status, conflicting instructions, corrections, and unresolved questions.
Executive guidance · Signal
Response ownership
Does every campaign-generated request reach an accountable receiver?
- Candidate local measure
- Routing, acknowledgment, repeat contact, unresolved work, and escalation signals.
Executive guidance · Signal
Longitudinal ownership
Can people and teams see who owns the next step across a route that may involve repeated contacts?
- Candidate local measure
- Locally defined repeated contacts, aged work, transition acceptance, unresolved routes, and experience feedback.
Executive guidance · Signal
Action closure
Did leaders complete and verify the improvement selected for the campaign window?
- Candidate local measure
- Assigned action, status, evidence of completion, and post-action review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Message alignment | Executive sponsor and operational lead |
| Response ownership | Operational owner and participating teams |
| Longitudinal ownership | Sending and receiving owners |
| Action closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Record the next owner, status, and approved follow-through route so responsibility does not disappear between contacts.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Message alignment | Do channels and partners communicate one current and appropriately bounded route? | Executive sponsor and operational lead | At campaign launch and close |
| Response ownership | Does every campaign-generated request reach an accountable receiver? | Operational owner and participating teams | At a locally defined cadence |
| Longitudinal ownership | Can people and teams see who owns the next step across a route that may involve repeated contacts? | Sending and receiving owners | At a locally defined cadence |
| Action closure | Did leaders complete and verify the improvement selected for the campaign window? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable diabetes detection and prevention route
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Positive screening result communicated and acknowledged | Patients do not recall or act on a new diagnosis | Emergency and ambulatory operations leads | Share of positive screens with documented notification and acknowledged next step |
| Receiving route for patients without a primary care provider | Results from specialty or emergency settings have no owner | Primary care access director | Share of positive screens with a scheduled primary care visit |
| Confirmatory testing for high-risk groups | Diabetes missed by first-line tests in people with cardiovascular disease | Cardiology and laboratory medical directors | Confirmatory test completion among eligible patients |
| Prevention program offered through more than one channel | Virtual-only offers exclude people without digital access | Population health leader | Enrollment by channel, age, race and ethnicity |
| Food insecurity screening linked to a food resource | Food barriers persist alongside clinical advice | Community health and social care lead | Share of positive food screens with a completed resource connection |
| Equitable offer of diabetes technology | Gaps in monitoring and pump use by race and ethnicity widen | Endocrinology service line lead | Technology use stratified by race, ethnicity and payer |
| Governance of risk tools used for outreach | Models miss groups the system most needs to reach | Chief medical information officer and quality committee | Periodic review of model sensitivity by subgroup |
Control points derived from the cited evidence [1], [3], [4], [5], [6], [12], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating prevention and results in ways people act on
Public campaigns can shift intentions toward prevention. Hawai’i’s campaign ran from July to October 2024, and a postcampaign survey of 860 at-risk adults aged 35 to 64 found that 40% reported exposure.[2] Exposed respondents had higher ratings of likelihood to join a prevention program than those not exposed.[2] Intention is not enrollment, so a campaign must connect to an intake that can respond quickly.
Message content mattered. Perceived positive health impact of participation was the strongest contributor to likelihood ratings.[2] The authors recommended that campaigns promote program effectiveness and the urgency of preventive action.[2] For health systems, that suggests describing what the program offers and what participants can expect, rather than repeating general risk warnings. Exposed respondents also held higher beliefs that developing diabetes was inevitable, a reminder that messages should pair urgency with a clear sense that prevention works.[2] Fatalism and hope can travel in the same campaign, so testing messages with the intended audience matters.
Communicating results is part of care quality. Only 46% of newly diagnosed emergency department patients recalled their diagnosis, and unawareness of the screening result was a reported barrier to follow-up.[1] A message delivered once in a busy setting may not be retained. Plain-language notification through more than one channel is a reasonable design response. Communication with clinicians matters too, since a specialty team that finds an elevated HbA1c must explain why the result matters and where the patient should go next.[4]
Participant voice should shape communication. In the tailored survivors program, 95% of participants would recommend it, while 75% were somewhat or very satisfied, slightly below the team’s benchmark.[10] Participants in the Michigan grocery program were primarily female and White, a reminder that outreach materials should be tested with the communities a system most needs to reach.[6]
Risk tools can help target outreach, but they need governance and plain explanation. An automated machine learning model reached an area under the curve of 0.909 for detecting undiagnosed diabetes, with sensitivity of 70.26% and positive predictive value of 64.10%.[12] In Indonesia, adding a risk score to blood glucose screening, which had 32.8% coverage, had an incremental cost-effectiveness ratio of $1,687 per quality-adjusted life-year compared with no screening.[7] Leaders who adopt such tools should say how they are used and review whom they miss.[12]

Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how World Diabetes Day communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Review one repeated-contact or cross-service route and correct a verified ownership or information gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how World Diabetes Day communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Review one repeated-contact or cross-service route and correct a verified ownership or information gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make World Diabetes Day a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Day observance
Turn World Diabetes Day into accountable action.
An executive-guidance framework for coordinated messaging, visible ownership, and a measured improvement cycle.
Leadership focus
Use this observance to examine navigation, longitudinal ownership, and specialty-care coordination. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, longitudinal ownership, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, transportation, affordability, food access, digital access, disability, and geographic availability.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, caregivers, primary care, specialty services, pharmacy, and community partners. Find one a confusing entry point, fragmented follow-through, or an unresolved navigation need, then test the locally approved route from entry through acknowledged follow-through.
- Define the purpose
- Align the entry point
- Support longitudinal navigation
- Manage response
- Review the campaign
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Content review status, conflicting instructions, corrections, and unresolved questions.
- Routing, acknowledgment, repeat contact, unresolved work, and escalation signals.
- Locally defined repeated contacts, aged work, transition acceptance, unresolved routes, and experience feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Patient Experience and Access Leaders
Staff communication template
During World Diabetes Day, our organization will connect awareness with a practical review of the information, access, longitudinal ownership, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
World Diabetes Day is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Koziatek CA, Annem V, Chan A, Fong J, Reddy H, Caldwell R, et al. Assessing connection to outpatient care among patients screening positive for previously undiagnosed diabetes in the emergency department: a combined retrospective cohort and prospective cohort survey study. BMC Health Services Research. 2026;26(1):1134. https://doi.org/10.1186/s12913-026-14935-y
- 2.Saiki K, Lim E, Nett B, Ogawa G, Ching LK, Kawasaki RM, et al. Encouraging Adults at Risk for Type 2 Diabetes to Enroll in Diabetes Prevention Programs Through a Media Campaign in Hawai’i: Cross-Sectional Study. JMIR Public Health and Surveillance. 2026;12:e90880. https://doi.org/10.2196/90880
- 3.Rego MLM, Barnett M, Siqueira Tavares de Melo MH, Rivadeneira A. US race/ethnic disparities in diabetes technologies: a systematic review and meta-analysis of 950 000 individuals. Journal of the Endocrine Society. 2026;10(8):bvag150. https://doi.org/10.1210/jendso/bvag150
- 4.Heiting C, Wickes CB, Katakam S, Herrera C, Li B, Intravia J, et al. Occurrence of Undiagnosed Diabetes Mellitus With Musculoskeletal Disorders of the Upper Extremity: Prospective Screening With Point‐of‐Care Haemoglobin A1c Fingerstick Testing. Musculoskeletal Care. 2026;24(3):e70256. https://doi.org/10.1002/msc.70256
- 5.Ni C, Zhao X, Liu X, Zhao K, Zhang W. Serum albumin-enhanced screening: A triage strategy and predictive model for OGTT in community-managed patients with coronary heart disease. Diabetes & Vascular Disease Research. 2026;23(4):14791641261474034. https://doi.org/10.1177/14791641261474034
- 6.Waselewski M, Waselewski E, Oshman L, Hatch K, Chang T. Hemoglobin A1c and Weight Changes Associated With Grocery Delivery and Low-Carbohydrate Education in Adults With Type 2 Diabetes and Food Insecurity: Observational Quality Improvement Cohort Study. JMIR Formative Research. 2026;10:e89459. https://doi.org/10.2196/89459
- 7.Rokhman MR, Hanifa RS, Niamuzisilawati E, At Thobari J, Postma MJ, Boersma C, et al. Economic Evaluation of Adopting a Risk Score for Diabetes Screening in Indonesia. Value in Health Regional Issues. 2026;56:101632. https://doi.org/10.1016/j.vhri.2026.101632
- 8.Ernest DK, Singh B, Hinojosa A, Imran A, Onugha EA, Sharma SV, et al. Food Insecurity and Cardiovascular-Kidney-Metabolic Syndrome–Related Conditions Among US Adults, National Health and Nutrition Examination Survey, 2015–2020. Preventing Chronic Disease. 2026;23:250372. https://doi.org/10.5888/pcd23.250372
- 9.Pál S, Sepsey A. Undiagnosed Diabetes in Metabolically Unhealthy Normal Weight Adults: A Cross-Sectional Analysis of National Health and Nutrition Examination Survey Cycle 2017–2020 in the United States. Journal of Clinical Medicine. 2026;15(4):1385. https://doi.org/10.3390/jcm15041385
- 10.Rodrigues APS, Cooper AJ, Llanos AAM, Fleming K, Pittman S, Peña A, et al. Feasibility and acceptability of a stress-management behavioral weight loss intervention for Black breast cancer survivors. Scientific Reports. 2026;16(1):18905. https://doi.org/10.1038/s41598-026-49330-4
- 11.Al Juboori R, Barker D, Lorusso K, Morgan R, Swindell E, Apu A, et al. Built Environment, Community Safety, and Diabetes in the Deep South: A County Level Geospatial Analysis. Journal of Racial and Ethnic Health Disparities. 2026:online ahead of print. https://doi.org/10.1007/s40615-026-03203-8
- 12.Liu J, Ssewamala F, An R, Ji M. Use of Automated Machine Learning to Detect Undiagnosed Diabetes in US Adults: Development and Validation Study. JMIR AI. 2025;4:e68260. https://doi.org/10.2196/68260
- 13.Sseguya W, Bahendeka S, Mody N, MacLennan S, Guntupalli AM. Prevalence and correlates of diagnosed and undiagnosed diabetes mellitus among adults in rural Uganda during the COVID-19 pandemic: an evaluation of a community-based screening programme. International Health. 2025;18(1):17-25. https://doi.org/10.1093/inthealth/ihaf050
- 14.Kuo S, Ye W, Wang D, McEwen LN, Villatoro Santos C, Herman WH. Cost-effectiveness of the National Diabetes Prevention Program: A Real-world, 2-Year Prospective Study. Diabetes Care. 2024;48(7):1180-1188. https://doi.org/10.2337/dc24-1110
- 15.Ng BP, Hawkins GT, Massey M, LaManna JB, Park C. Digital Divide Among Medicare Beneficiaries and the Diabetes Prevention Program. American Journal of Preventive Medicine. 2024;67(5):746-752. https://doi.org/10.1016/j.amepre.2024.06.019
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Unawareness of diabetes and detection model performance | [12] | 2025 | Executive opening | Model built on national survey data from 1999 to 2020; performance in clinical workflows not tested. |
| Emergency department screening yield and connection to outpatient care | [1] | 2026 | Continuum of care | Four sites of one health system; survey response rate of 50%; self-reported follow-up. |
| Undiagnosed diabetes among normal-weight adults with metabolic risk | [9] | 2026 | Current evidence | Cross-sectional national data from 2017 to March 2020; wide confidence interval for the Asian subgroup. |
| Missed diabetes in coronary heart disease without confirmatory testing | [5] | 2026 | Current evidence | Survey data from 2007 to 2016 with 287 patients with coronary heart disease; prediction model derived within the same survey data. |
| Food insecurity and cardiovascular-kidney-metabolic conditions | [8] | 2026 | Current evidence | Cross-sectional, self-reported conditions; associations only. |
| County-level diabetes burden, infrastructure and racial composition in the Deep South | [11] | 2026 | Equity and trust | Ecological correlations for 2022; cannot be applied to individuals. |
| Undiagnosed diabetes found through community health worker screening in rural Uganda | [13] | 2025 | Human infrastructure | Three rural districts during the COVID-19 pandemic; non-U.S. setting. |
| Point-of-care HbA1c screening in a specialty clinic and lack of primary care | [4] | 2026 | Continuum of care | Single orthopedic hand clinic; 84 patients. |
| Cost-effectiveness of risk-score screening and linkage to prediabetes interventions | [7] | 2026 | Continuum of care | Modeled hypothetical population in Indonesia; payer perspective. |
| Real-world cost and value of prevention program enrollment | [14] | 2024 | Access | Employer-insured workforce; cost reduction confidence interval crossed zero; self-selection adjusted by weighting. |
| Digital access among potentially eligible Medicare beneficiaries | [15] | 2024 | Access | 2020 survey data; computer and internet access, not program enrollment. |
| Grocery delivery with education for adults with diabetes and food insecurity | [6] | 2026 | Access | Nonrandomized, no control group; 83 participants, mostly White and female. |
| Racial and ethnic disparities in diabetes technology use | [3] | 2026 | Equity and trust | Observational studies with moderate to substantial heterogeneity; electronic record data. |
| Tailored prevention curriculum feasibility and acceptability | [10] | 2026 | Human infrastructure | Single-arm study of 20 women; four-month follow-up. |
| Media campaign exposure and intention to join a prevention program | [2] | 2026 | Public communication | Cross-sectional online survey; outcome is self-reported likelihood, not enrollment. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

